"City of Hope provides Antelope Valley, Lancaster and its surrounding communities with incomparable cancer care and innovative treatments close to home. The convenient location, just off Highway 14, puts our patients within easy reach of additional medical, laboratory and diagnostic radiology services, such as ultrasound, mammograms, MRI (magnetic resonance imaging) and CT (computed tomography) scans. The light and bright 25,000-square-foot facility offers multiple exam and treatment rooms for patient comfort and convenience, expanding access to City of Hope’s world-class level of care. We are dedicated to creating a positive and healing environment in our spacious chemotherapy and infusion area."

During the past decade, City of Hope Antelope Valley conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 22 clinical trials were completed, i.e. on average, 53.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 21 clinical trials were completed. i.e. 262.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "City of Hope Antelope Valley" #1 sponsor was "SWOG Cancer Research Network" with 15 trials, followed by "City of Hope Medical Center" with 14 trials sponsored, "National Cancer Institute (NCI)" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "City of Hope Antelope Valley" #1 collaborator was "National Cancer Institute (NCI)" with 32 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Novartis" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "City of Hope Antelope Valley" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Stage IV Breast Cancer AJCC v6 and v7" (6 trials), "HER2/Neu Negative" (4 trials) and "Breast Cancer" (3 trials). Many other conditions were trialed in "City of Hope Antelope Valley" in a lesser frequency.

Most popular intervention types in "City of Hope Antelope Valley" are "Drug" (41 trials), "Other" (37 trials), "Biological" (21 trials), "Procedure" (6 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Questionnaire Administration" (10 trials), "Quality-of-Life Assessment" (9 trials), "Pembrolizumab" (7 trials) and "Nivolumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "City of Hope Antelope Valley" are 39 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "City of Hope Antelope Valley". undefined are not yet recruiting, 8 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in City of Hope Antelope Valley, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in City of Hope Antelope Valley, 3 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".